Skip to main content
Log in

Use of fluconazole in the treatment ofCandida albicans hydrocephalus shunt infection

  • Letters
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Bayston R Hydrocephalus shunt infections and their treatment. Journal of Antimicrobial Chemotherapy 1985, 15: 259–261.

    Google Scholar 

  2. Shapiro SF, Javed T, Mealey J Candida albicans shunt infection. Pediatric Neuroscience 1989, 15: 125–130.

    Google Scholar 

  3. Fisher JF, Dewald J Parkinsonism associated with intraventricular amphotericin B. Journal of Antimicrobial Chemotherapy 1981, 12: 97–99.

    Google Scholar 

  4. Hay RJ Antifungal therapy and the new azole compounds. Journal of Antimicrobial Chemotherapy 1991, 28, Supplement A: 35–46.

    Google Scholar 

  5. Sugar AM, Saunders C Oral fluconazole as suppressive therapy of disseminated cryptococcosis in patients with acquired immunodeficiency syndrome. American Journal of Medicine 1988, 85: 481–489.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cruciani, M., Di Perri, G., Molesini, M. et al. Use of fluconazole in the treatment ofCandida albicans hydrocephalus shunt infection. Eur. J. Clin. Microbiol. Infect. Dis. 11, 957 (1992). https://doi.org/10.1007/BF01962387

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01962387

Keywords

Navigation